Spring Valley, NY, Sept. 5, 2006 — Par Pharmaceutical Companies, Inc. (NYSE:PRX) will be presenting at Bear Stearns 19th Annual Healthcare Conference on Tuesday, September 12, at 4:00 pm EDT at The Grand Hyatt New York.
The audio-only live webcast will be accessible through the Bear Stearns website at http://cc.talkpoint.com/BEAR002/091106a_cy/?entity=par or through the Par Pharmaceutical website at www.parpharm.com. A replay will be available at the same link address for 60 days after the conference and will begin within 3 hours after the presentation.
Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. In 2005, Par received approval for and introduced the appetite stimulant Megace® ES, its first branded pharmaceutical product. Par’s Generic Products Division is committed to providing high-quality pharmaceuticals that are affordable and accessible to patients. Par manufactures, markets or licenses more than 110 generic drugs. For press release and other company information, visit www.parpharm.com.
Contacts:
Stephen J. Mock
Cecelia C. Heer
Par Pharmaceutical Companies, Inc.
(201) 802-4000
|
